Share this article:


Titan School Solutions recently raised $5.2 million Series A to help grow its school nutrition program.

The Irvine-based software company’s platform helps automate school lunch lines, streamline payment, and allow real-time communication with parents.

Titan currently serves nearly 1 million students across 150 school districts nationwide.

Proceeds will be used to enhance Titan’s technology platform and grow its sales and marketing teams.

Get the latest OC business and Coronavirus updates

“This round of funding will not only help extend our value with existing users, but also scale our ability to serve new school districts and nutrition professionals who would significantly benefit from our solutions,” company President Brad Blankenship said in a news release.

Wavemaker Partners in Los Angeles and Irvine-based Springboard Ventures led the round. Irvine-based Rezven Partners LLC also contributed.

Titan is a portfolio company of Irvine-based accelerator and digital solution provider Cie Digital Labs.

Cie Chief Executive Anderee Berengian told the Business Journal that Titan’s cloud-based software enables school districts to modernize lunch lines, spend less resources on managing meal plans, as well as enable parents to have more control and transparency over what students eat. He is also a managing partner at Rezven.


Watch for Allevion Therapeutics Inc. this year. It recently appointed Troy Barring to chief executive this month as it prepares for Series A funding.

The seasoned medical device executive joined Allevion’s board a year ago and was previously chief operating officer of Avita Medical and Orthozon Technologies.

The Irvine-based medical device maker develops “smartcuffs”, a smart wearable-tech device that looks like a digital watch, but is designed to reduce hand and leg tremors, specifically essential tremor, a nervous system disorder.

The wearable delivers “noninvasive, multimodal energy therapy to alter the activity of nerves responsible for the tremor,” according to a company press release.

“Having been in the medical device space for 25 years, the two most critical things you need to have is a great product that serves an unmet need from a customer standpoint and a really outstanding team helping you deliver the product,” Barring said in a phone interview.

He pointed out the condition affects 10 million people in the U.S. and more than 160 million people worldwide.

Allevion, founded in 2017, is part of the portfolio of Adventus Ventures LLC, an Irvine-based medical device company incubator and early-stage venture capital firm.

Barring said seed funding from Adventus Ventures led to a successful prototype of the Allevx device, and proceeds from the new round will be used for continued product development and commercialization.


• Software technology company NuEyes has partnered with virtual reality solutions company Pico Interactive Inc. on a new VR headset that enhances vision for people with eye conditions such as macular degeneration, glaucoma and retinitis pigmentosa.

“At NuEyes, we are extremely passionate about bringing the right innovation to market to help the visually impaired. Partnering with Pico Interactive was the clear choice for the next generation of ‘Easy’ products,” said Chief Executive Mark Greget in a statement.

The Newport Beach-based device maker develops smart glasses for those with visual impairments.

Its latest product, NuEyes e2, features an HD camera, contrast and brightness settings, 18-times magnification and text to speech functionality.

It retails for $2,995 and will begin shipping in the first quarter this year.

For digital licensing requests for this article, Contact Kim Lopez